Nitroimidazole patent EP3810137A1 filed 1st Apr, IRP Health
Summary
Nitroimidazole patent EP3810137A1 filed 1st Apr, IRP Health
Archived snapshot
Apr 9, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
NITROIMIDAZOLE FORMULATIONS
Publication EP3810137A1 Kind: A1 Apr 01, 2026
Applicants
IRP Health Pty Ltd
Inventors
XIAO, Zhicheng, YU, David Xiang, POUTON, Colin William, HE, Zhiyong
IPC Classifications
A61K 31/4375 20060101AFI20220203BHEP A61K 31/4164 20060101ALI20220203BHEP A23K 20/137 20160101ALI20220203BHEP A23K 20/121 20160101ALI20220203BHEP A23K 20/195 20160101ALI20220203BHEP A61P 31/04 20060101ALI20220203BHEP A23K 50/30 20160101ALI20220203BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.